Mellis Vet 0.2 mg for cats is a non-steroidal anti-inflammatory drug (NSAID) based on meloxicam, indicated for the relief of pain and inflammation in felines. It acts as a preferential inhibitor of the COX-2 enzyme, reducing the production of prostaglandins responsible for the inflammatory process, with analgesic, antipyretic and anti-inflammatory action. Indications Control of acute pain and inflammation in cats, such as post-operative (e.g. ovariosalpingohysterectomy) Treatment of various inflammatory conditions as per veterinary assessment Composition Each tablet contains 0.2 mg of meloxicam Excipients qsp 70 mg Recommended dosage Initial dose: 0.1 mg/kg (equivalent to 1 0.2 mg tablet for a 2 kg cat) on the first day Maintenance dose: 0.05 mg/kg (half a 0.2 mg tablet for a 2 kg cat) every 24 hours, for up to 14 days Example for 4 kg cats: 2 tablets on the first day and 1 tablet on the following days Administration exclusively orally, preferably with food Presentation Blister with 10 biscored tablets to facilitate dose division Safety and considerations Product for veterinary use, must be used under prescription and professional supervision Clinical studies indicate 100% efficacy in controlling pain and inflammation in cats undergoing surgery Avoid concomitant use with other anti-inflammatories, anticoagulants, diuretics and nephrotoxic drugs to reduce the risk of adverse effects. In summary, Mellis Vet 0.2 mg is an effective and safe anti-inflammatory for cats, indicated for controlling pain and inflammation, with dosage adjusted to the animal's weight and daily oral administration for up to 14 days.
